Last reviewed · How we verify
Ritlecitinib higher dose (ritlecitinib-higher-dose)
At a glance
| Generic name | ritlecitinib-higher-dose |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 3 |
Approved indications
Common side effects
- Abdominal discomfort
- Dry mouth
- Lip dry
- Fatigue
- Nasopharyngitis
- Arthralgia
- Neck pain
- Nasal dryness
- Haematoma
- Dry eye
- Abdominal pain
- Diarrhoea
Key clinical trials
- A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. (PHASE3)
- A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata (PHASE3)
- A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |